GlaxoSmithKline chose Simon Dingemans, a Goldman Sachs M&A specialist, to be its next chief financial officer.
WSJ.com: What's News US, Wall Street Journal
Wed, 09/08/2010 - 7:51am
GlaxoSmithKline chose Simon Dingemans, a Goldman Sachs M&A specialist, to be its next chief financial officer.